BioSpace News Archive

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the submission of a New Drug Application to the Ministry of Health, Labour and Welfare in Japan for its COVID-19 vaccine by its partner Takeda Pharmaceutical Company Limited.

Immix Biopharma, Inc. announced the pricing of its initial public offering of 4,200,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $21,000,000 before deducting underwriting discounts, commissions and offering expenses.

Bionique Testing Laboratories LLC, a global leader in mycoplasma testing services for the biologics and life- sciences industries, announced that it has been 100% acquired by a subsidiary of Japan- based healthcare pioneer Asahi Kasei Medical Co., Ltd.

Rakuten Medical, Inc announced that the U.S. Food and Drug Administration has accepted the company’s Investigational New Drug application to begin clinical studies of RM-1995 photoimmunotherapy in patients with advanced cutaneous squamous cell carcinoma or with head and neck squamous cell carcinoma.